➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Baxter
Moodys
Medtronic
Merck

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020907


Email this page to a colleague

« Back to Dashboard

NDA 020907 describes ACTIVELLA, which is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. Additional details are available on the ACTIVELLA profile page.

The generic ingredient in ACTIVELLA is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.
Summary for 020907
Tradename:ACTIVELLA
Applicant:Amneal
Ingredient:estradiol; norethindrone acetate
Patents:0
Pharmacology for NDA: 020907
Mechanism of ActionEstrogen Receptor Agonists
Suppliers and Packaging for NDA: 020907
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907 NDA Amneal Pharmaceuticals LLC 60846-231 60846-231-01 1 BLISTER PACK in 1 CARTON (60846-231-01) > 28 TABLET, FILM COATED in 1 BLISTER PACK
ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907 NDA Amneal Pharmaceuticals LLC 60846-232 60846-232-01 1 BLISTER PACK in 1 CARTON (60846-232-01) > 28 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG;0.5MG
Approval Date:Nov 18, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG;0.1MG
Approval Date:Dec 28, 2006TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Express Scripts
McKinsey
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.